Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor 
signaling

Nagao, Hirofumi; Cai, Weikang; Brandao, Bruna B.; Wewer Albrechtsen, Nicolai J.; Steger, Martin; Gattu, Arijeet K.; Pan, Hui; Dreyfuss, Jonathan M.; Wunderlich, Frank Thomas; Mann, Matthias; Kahn, Ronald C.

doi:10.1172/JCI161472

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling

MPS-Authors

/persons/resource/persons147349

Wunderlich, Frank Thomas
Wunderlich – Obesity and Cancer, Department Brüning, Max Planck Institute for Metabolism Research, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Nagao, H., Cai, W., Brandao, B. B., Wewer Albrechtsen, N. J., Steger, M., Gattu, A. K., et al. (2023). Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling. Journal of Clinical Investigation (New York, NY), 133(4): e161472. doi:10.1172/JCI161472.

Cite as: https://hdl.handle.net/21.11116/0000-000C-E7E4-E

Abstract

There is no abstract available